Roberto Chiarle
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma (NCT06803875) | Roberto Chiarle | 2025-01-31 |
Track Roberto Chiarle automatically
Every clearance here is in the API, with alerts when new ones post.